Analysts expect over 2019 decreasing revenue Galapagos

Over the current book year the total revenue will be 181,84 million euros (consensus estimates). This is rather significant lower than 2018's revenue of 317,85 million euros.

Historical revenues and results Galapagos plus estimates 2019


The analysts expect for 2019 a net loss of 202 million euros. For this year most of the analysts expect a loss per share of 4,72 euros. The price/earnings-ratio therefore equals -29,71.

For this year analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies equals a poor 1 percent.

Latest estimates around 177 euros

The most recent recommendations for the biotech company are from Sanford C. Bernstein & Co, Citigroup and Berenberg.

Based on the current number of shares Galapagos's market capitalization equals 7,14 billion euros. The Galapagos stock was the past 12 months quite volatile. Since last October the stock is even 55 percent higher. This year the stock price moved between 74 and 171 euro.

Price data Galapagos 2007-2019

stock galapagos

Click here for dividend . At 10.26 the stock trades 0 percent lower at 140,25 euros. Nieuwsdienst: +31 084-0032-842

Copyright B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.